Global Hunter Syndrome Treatment Market Outlook 2021: Global Opportunity and Demand Analysis, Market Forecast to 2028

The hunter syndrome treatment market is anticipated to grow with a CAGR of 5.4% over the forecast period of 20202028. According to a study published by Insure Insights on the hunter syndrome treatment market, the increasing number of patients and the rise in government initiatives to increase awareness associated with the treatment are some of the driving factors for the growth of the market. Additionally, the rise in investments in the development of drugs by pharmaceutical companies is considered another factor driving the growth of the market across the globe.
The Hunter Syndrome Treatment Market is expected to be driven by an increasing government initiative and an increasing number of patients.
Hunter Syndrome is a very rare, inherited genetic disorder that occurs due to missing or malfunctioning enzymes. The basic functionality of these enzymes is to break down certain complex molecules. However, due to the loss of these enzymes, the complex molecules hamper the abilities of the human body, including permanent, progressive damage affecting appearance, organ function, mental development, and physical abilities. The rise in the number of patients across the globe is one of the major factors driving the growth of the market. For instance, 970 patients were enrolled with the disorder in 2014 under the Hunter Outcome Survey (HOC), which eventually reached 1195 patients in 2017.

Furthermore, the National Institute of Health (NIH) in 2018 published data which states that Hunter syndrome affects around 1 in 160,000 males globally. Additionally, it also states that the risk of developing this disease is low among women because they inherit two X chromosomes and one of them can provide a functioning gene if the other X chromosome is defective. However, in men, there is no other X chromosome that can function in place of the defective one.
Early Adoption of Enzyme Replacement Therapy (ERT): Contribution to the Growth of the Global Hunter Syndrome Treatment Market
Based on treatment type, the market is categorized into hematopoietic stem cell transplant (HSCT), enzyme replacement therapy (ERT), and others. Currently, enzyme replacement therapy (ERT) dominates the market by holding the largest share based on treatment type and is expected to dominate in the near future due to the early adoption of this treatment type. Additionally, this type of treatment also increases the concentration of the missing enzyme within an individuals body, leading to improved cellular metabolic processes.
Based on end-users, the global hunter syndrome treatment market has been segmented into hospitals, specialty clinics, and others. Due to the adoption of advanced treatment and well-equipped medical facilities, hospitals account for the largest share of the end-user segment. Additionally, the presence of expertise and increasing R&D facilities within the premise is also boosting the growth of the market.
Rising Investments in the Healthcare Industry in the North American Market
North America has developed countries such as the US and Canada that have well-established healthcare infrastructure, which is one of the major factors driving the growth of the Hunter syndrome treatment market. Furthermore, rising awareness among individuals in the region, rising investments, and funding in R&D activities in the region are propelling the regions market growth. Similarly, the reimbursement policies in the US for expensive drugs such as ELAPRASE are also contributing to the growth of the market. The presence of various companies such as ArmaGen, Inc., RegenxBio Inc., and others are investing in the development of drugs for the hunter syndrome treatment market.

Players will concentrate on the development of novel and advanced drugs for the Hunter Syndrome market.
The global hunter syndrome treatment market is expected to grow with a significant CAGR due to the presence of various companies, including Takeda Pharmaceutical Company Limited, GC Pharma, JCR Pharmaceuticals Co., Ltd., Sangamo Therapeutics, Inc., and others, who are contributing to the growth of the market by developing new drugs and treatment methods.
Takeda Pharmaceutical Company Limited: In April 2019, the company acquired Shire Plc. to increase its market presence and sell ELAPRASE drugs for the hunter-syndrome treatment market. This acquisition led to strengthening the companys hold on the market.
In April 2019, GC Pharma signed a licensing agreement with Clinigen Group plc to distribute and commercialize Hunterase in Japan with the help of Clinigen Group plc. This partnership leads to the geographical expansion of GC Pharma for the hunter syndrome market.

Scope of the Report

By Treatment
Enzyme Replacement Therapy (ERT)
Hematopoietic Stem Cell Transplant (HSCT)
Others

By Route of Administration
Intravenous
Intracerebroventricular (ICV)/ Intrathecal

By End-User
Hospitals
Specialty Clinics
Others

By Region
North America
Europe
Asia Pacific
Rest Of World

Key Reasons to Purchase this Report
1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders a definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.

Chapter 1 Overview And Scope
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation

Chapter 2 Executive Summary

Chapter 3 Global Hunter Syndrome Treatment Market Forces
3.1 Whats Driving the Market
3.2 Porters Five Forces Analysis
3.2.1 Power of Suppliers
3.2.2 Threats From New Entrants
3.2.3 Power of Buyer
3.2.4 Threat From Substitute Product
3.2.5 Degree of Competition

Chapter 4 Global Hunter Syndrome Treatment Market -Industry Snapshots
4.1 Overview
4.1.1 Global Hunter Syndrome Treatment Market Value, 2019 - 2030, (US$ Mn)
4.2 Market Overview
4.2.1 Drivers Analysis
4.2.2 Restraint/Challenges analysis
4.2.3 Opportunity Analysis
4.3 Supply Chain/Value Chain Analysis
4.4 Market SWOT Analysis

Chapter 5 Global Hunter Syndrome Treatment Market Analysis, By Treatment
5.1 Overview
5.2 Enzyme Replacement Therapy (ERT)
5.3 Hematopoietic Stem Cell Transplant (HSCT)
5.4 Others

Chapter 6 Global Hunter Syndrome Treatment Market Analysis, by By Route of Administration
6.1 Overview
6.1.1 Intravenous
6.1.2 Intracere broventricular (ICV)/ Intrathecal

Chapter 7 Global Hunter Syndrome Treatment Market Analysis, by End-User
7.1 Overview
7.1.1 Hospitals
7.1.2 Specialty Clinics
7.1.3 Others

Chapter 8 Hunter Syndrome Treatment Market Analysis by Region
8.1 Key Findings for Hunter Syndrome Treatment Market- By region
8.2 Overview
8.2.1 Global Hunter Syndrome Treatment Market Analysis, By Treatment, 2019 - 2030
8.2.2 Global Hunter Syndrome Treatment Market Analysis, By By Route of Administration, 2019 - 2030
8.2.3 Global Hunter Syndrome Treatment Market Analysis, By End User, 2019 - 2030
8.3 Hunter Syndrome Treatment Market North America
8.3.1 Overview
8.3.2 U.S.
8.3.3 Canada
8.3.4 Mexico
8.4 Hunter Syndrome Treatment Market Europe
8.4.1 Overview
8.4.2 Germany
8.4.3 United Kingdom
8.4.4 France
8.4.5 Italy
8.4.6 Rest Of Europe
8.5 Hunter Syndrome Treatment Market Asia Pacific
8.5.1 Overview
8.5.2 China
8.5.3 Japan
8.5.4 India
8.5.5 Rest of APAC
8.6 Hunter Syndrome Treatment Market Rest of the World
8.6.1 Overview
8.6.2 Middle East & Africa (MEA)
8.6.3 Latin America

Chapter 9 Market Competition Analysis
9.1 Market Share/Positioning Analysis
9.1.1 Market Positioning of Key Hunter Syndrome Treatment Vendors, 2018
9.1.2 Key Strategies Adopted by the Leading Players

Chapter 10 Company Profiles- Snapshot
10.1 Takeda Pharmaceutical Company Limited
10.2 ArmaGen, Inc.
10.3 BioMarin Pharmaceutical
10.4 GC Pharma
10.5 JCR Pharmaceuticals Co Ltd.
10.6 RegenxBio Inc.
10.7 Sangamo Therapeutics, Inc.
10.8 Inventiva S.A.
10.9 Denali Therapeutics Inc.
10.10 Bioasis Technologies Inc.
10.11 BioMarin Pharmaceutical, Inc.
10.12 Esteve.
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies

Chapter 11 Appendix
11.1 Research Methodology
11.2 Data Triangulation
11.3 Data Sources
11.4 Assumptions
11.5 Approach Adopted
11.6 Disclaimer

List Of Tables

TABLE 1 Hunter Syndrome Treatment Market, By Enzyme Replacement Therapy (ERT), 2018 - 2026 (USD Million)
TABLE 2 Hunter Syndrome Treatment Market, By Hematopoietic Stem Cell Transplant (HSCT), 2018 - 2026 (USD Million)
TABLE 3 Hunter Syndrome Treatment Market, By Others, 2018 - 2026 (USD Million)
TABLE 4 Hunter Syndrome Treatment Market By Intravenous, 2018 - 2026 (USD Million)
TABLE 5 Hunter Syndrome Treatment Market By Intracere broventricular (ICV)/ Intrathecal, 2018 - 2026 (USD Million)
TABLE 6 Hunter Syndrome Treatment Market By Hospitals, 2018 - 2026 (USD Million)
TABLE 7 Hunter Syndrome Treatment Market By Specialty Clinics, 2018 - 2026 (USD Million)
TABLE 8 Hunter Syndrome Treatment Market By Others, 2018 - 2026 (USD Million)
TABLE 9 Global Hunter Syndrome Treatment Market Value, By Treatment, 2019 - 2030 (US$ Mn)
TABLE 10 Global Hunter Syndrome Treatment Market Value, By By Route of Administration, 2019 - 2030 (US$ Mn)
TABLE 11 Global Hunter Syndrome Treatment Market Value, By End User, 2019 - 2030 (US$ Mn)
TABLE 12 Hunter Syndrome Treatment Market Analysis by North America, By Country (USD Million), 2018-2026
TABLE 13 U.S. Hunter Syndrome Treatment Market, By Treatment, 2018 - 2026 (USD Million)
TABLE 14 U.S. Hunter Syndrome Treatment Market, By By Route of Administration, 2018 - 2026 (USD Million)
TABLE 15 U.S. Hunter Syndrome Treatment Market, By End User, 2018 - 2026 (USD Million)
TABLE 16 Canada Hunter Syndrome Treatment Market, By Treatment, 2018 - 2026 (USD Million)
TABLE 17 Canada Hunter Syndrome Treatment Market, By By Route of Administration, 2018 - 2026 (USD Million)
TABLE 18 Canada Hunter Syndrome Treatment Market, By End User, 2018 - 2026 (USD Million)
TABLE 19 Mexico Hunter Syndrome Treatment Market, By Treatment, 2018 - 2026 (USD Million)
TABLE 20 Mexico Hunter Syndrome Treatment Market, By By Route of Administration, 2018 - 2026 (USD Million)
TABLE 21 Mexico Hunter Syndrome Treatment Market, By End User, 2018 - 2026 (USD Million)
TABLE 22 Hunter Syndrome Treatment Market Analysis by Europe by Country (USD Million), 2018-2026
TABLE 23 Germany Hunter Syndrome Treatment Market, By Treatment, 2018 - 2026 (USD Million)
TABLE 24 GermanyHunter Syndrome Treatment Market, By By Route of Administration, 2018 - 2026 (USD Million)
TABLE 25 Germany Hunter Syndrome Treatment Market, By End User, 2018 - 2026 (USD Million)
TABLE 26 United Kingdom Hunter Syndrome Treatment Market, By Treatment, 2018 - 2026 (USD Million)
TABLE 27 United Kingdom Hunter Syndrome Treatment Market, By By Route of Administration, 2018 - 2026 (USD Million)
TABLE 28 United Kingdom Hunter Syndrome Treatment Market, By End User, 2018 - 2026 (USD Million)
TABLE 29 France Hunter Syndrome Treatment Market, By Treatment, 2018 - 2026 (USD Million)
TABLE 30 France Hunter Syndrome Treatment Market, By By Route of Administration, 2018 - 2026 (USD Million)
TABLE 31 France Hunter Syndrome Treatment Market, By End User, 2018 - 2026 (USD Million)
TABLE 32 Italy Hunter Syndrome Treatment Market, By Treatment, 2018 - 2026 (USD Million)
TABLE 33 Italy Hunter Syndrome Treatment Market, By By Route of Administration, 2018 - 2026 (USD Million)
TABLE 34 Italy Hunter Syndrome Treatment Market, By End User, 2018 - 2026 (USD Million)
TABLE 35 Rest Of Europe Hunter Syndrome Treatment Market, By Treatment, 2018 - 2026 (USD Million)
TABLE 36 Rest Of Europe Hunter Syndrome Treatment Market, By By Route of Administration, 2018 - 2026 (USD Million)
TABLE 37 Rest of Europe Hunter Syndrome Treatment Market, By End User, 2018 - 2026 (USD Million)
TABLE 38 Hunter Syndrome Treatment Market Analysis by Asia Pacific by Country (USD Million), 2018-2026
TABLE 39 China Hunter Syndrome Treatment Market, By Treatment, 2018 - 2026 (USD Million)
TABLE 40 China Hunter Syndrome Treatment Market, By By Route of Administration, 2018 - 2026 (USD Million)
TABLE 41 China Hunter Syndrome Treatment Market, By End User, 2018 - 2026 (USD Million)
TABLE 42 Japan Hunter Syndrome Treatment Market, By Treatment, 2018 - 2026 (USD Million)
TABLE 43 Japan Hunter Syndrome Treatment Market, By By Route of Administration, 2018 - 2026 (USD Million)
TABLE 44 Japan Hunter Syndrome Treatment Market, By End User, 2018 - 2026 (USD Million)
TABLE 45 IndiaHunter Syndrome Treatment Market, By Treatment, 2018 - 2026 (USD Million)
TABLE 46 IndiaHunter Syndrome Treatment Market, By By Route of Administration, 2018 - 2026 (USD Million)
TABLE 47 India Hunter Syndrome Treatment Market, By End User, 2018 - 2026 (USD Million)
TABLE 48 Rest of APAC Hunter Syndrome Treatment Market, By Treatment, 2018 - 2026 (USD Million)
TABLE 49 Rest of APAC Hunter Syndrome Treatment Market, By By Route of Administration, 2018 - 2026 (USD Million)
TABLE 50 Rest of APAC Hunter Syndrome Treatment Market, By End User, 2018 - 2026 (USD Million)
TABLE 51 Hunter Syndrome Treatment Market Analysis by Rest of the World , by Region(USD Million), 2018-2026
TABLE 52 Middle East & Africa (MEA)Hunter Syndrome Treatment Market, By Treatment, 2018 - 2026 (USD Million)
TABLE 53 Middle East & Africa (MEA)Hunter Syndrome Treatment Market, By By Route of Administration, 2018 - 2026 (USD Million)
TABLE 54 Middle East & Africa (MEA)Hunter Syndrome Treatment Market, By End User, 2018 - 2026 (USD Million)
TABLE 55 Latin America Hunter Syndrome Treatment Market, By Treatment, 2018 - 2026 (USD Million)
TABLE 56 Latin America Hunter Syndrome Treatment Market, By By Route of Administration, 2018 - 2026 (USD Million)
TABLE 57 Latin America Hunter Syndrome Treatment Market, By End User, 2018 - 2026 (USD Million)

List Of Figures

FIG. 1 Global Hunter Syndrome Treatment : Market Segmentation
FIG. 2 Global Hunter Syndrome Treatment Market Value, 2019 - 2030, (US$ Mn)
FIG. 3 Global Hunter Syndrome Treatment Market Value Contribution, By Treatment, 2019 & 2026 (%)
FIG. 4 Global Hunter Syndrome Treatment Market Value Contribution, By By Route of Administration, 2019 & 2026 (%)
FIG. 5 Global Hunter Syndrome Treatment Market Value Contribution, By End-User, 2019 & 2026 (%)
FIG. 6 Global Hunter Syndrome Treatment Market Value, 2019 - 2030, (US$ Mn)
FIG. 7 North America Hunter Syndrome Treatment Market By Country (USD Million), 2019 - 2030
FIG. 8 Hunter Syndrome Treatment By Treatment North America
FIG. 9 Hunter Syndrome Treatment Market By By Route of Administration North America
FIG. 10 Hunter Syndrome Treatment By End User North America
FIG. 11 Hunter Syndrome Treatment U.S. outlook, 2019 & 2026
FIG. 12 Hunter Syndrome Treatment Canada outlook, 2019 & 2026
FIG. 13 Hunter Syndrome Treatment Mexico outlook, 2019 & 2026
FIG. 14 Europe Hunter Syndrome Treatment Market By Country (USD Million), 2019 - 2030, (US$ Mn)
FIG. 15 Hunter Syndrome Treatment Market Treatment Europe
FIG. 16 Hunter Syndrome Treatment Market By Route of Administration Europe
FIG. 17 Hunter Syndrome Treatment Market End User Europe
FIG. 18 Hunter Syndrome Treatment Germany outlook, 2019 & 2026
FIG. 19 Hunter Syndrome Treatment United Kingdom outlook, 2019 & 2026
FIG. 20 Hunter Syndrome Treatment France outlook, 2019 & 2026
FIG. 21 Hunter Syndrome Treatment Italy outlook, 2019 & 2026
FIG. 22 Hunter Syndrome Treatment Rest Of Europe outlook, 2019 & 2026
FIG. 23 Asia Pacific Hunter Syndrome Treatment Market By Country (USD Million), 2019 - 2030
FIG. 24 Hunter Syndrome Treatment Market Treatment Asia Pacific
FIG. 25 Hunter Syndrome Treatment Market By Route of Administration Asia Pacific
FIG. 26 Hunter Syndrome Treatment Market End User Asia Pacific
FIG. 27 Hunter Syndrome Treatment China outlook, 2019 & 2026
FIG. 28 Hunter Syndrome Treatment Japan outlook, 2019 & 2026
FIG. 29 Hunter Syndrome Treatment India outlook, 2019 & 2026
FIG. 30 Hunter Syndrome Treatment Rest of APAC outlook, 2019 & 2026
FIG. 31 Rest of the World Hunter Syndrome Treatment Market By Country (USD Million), 2019 - 2030
FIG. 32 Hunter Syndrome Treatment Market Treatment Rest of the World
FIG. 33 Hunter Syndrome Treatment Market By Route of Administration Rest of the World
FIG. 34 Hunter Syndrome Treatment Market End User Rest of the World
FIG. 35 Hunter Syndrome Treatment Middle East & Africa (MEA)outlook, 2019 & 2026
FIG. 36 Hunter Syndrome Treatment Latin America outlook, 2019 & 2026
FIG. 38 Global Hunter Syndrome Treatment Market: Research Methodology
FIG. 39 Top-Down and Bottom Up Approach


Companies Mentioned

ArmaGen Inc.
Avrobio, Inc.
Bioasis Technologies Inc.
BioMarin Pharmaceutical Inc.
CANbridge Life Sciences Ltd.
Clinigen Group PLC
Denali Therapeutics Inc.
Esteve
GC Pharma
Inventiva S.A.

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available